<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomarkers</journal-id><journal-id journal-id-type="publisher-id">tbmk</journal-id><journal-title-group><journal-title>Biomarkers</journal-title></journal-title-group><issn pub-type="ppub">1354-750X</issn><issn pub-type="epub">1366-5804</issn><publisher><publisher-name>Informa Healthcare</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21108560</article-id><article-id pub-id-type="pmc">3026342</article-id><article-id pub-id-type="doi">10.3109/1354750X.2010.533287</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Urinary excretion of the acrylonitrile metabolite 2-cyanoethylmercapturic acid is correlated with a variety of biomarkers of tobacco smoke exposure and consumption</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Minet</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cheung</surname><given-names>Francis</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Errington</surname><given-names>Graham</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sterz</surname><given-names>Katharina</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Scherer</surname><given-names>Gerhard</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><aff id="au1"><label>1</label>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK</aff><aff id="au2"><label>2</label>Analytisch-biologisches Forschungslabor GmbH, Goethestrasse 20, 80336 Munich, Germany</aff></contrib-group><author-notes><corresp>Address for Correspondence: Dr Emmanuel Minet, British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK, Phone: +44-(0)2380 588 997, Fax: +44-(0)2380 793 076, E-mail: <email>emmanuel_minet@BAT.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>25</day><month>11</month><year>2010</year></pub-date><volume>16</volume><issue>1</issue><fpage>89</fpage><lpage>96</lpage><history><date date-type="received"><day>19</day><month>8</month><year>2010</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2011 Informa UK, Ltd.</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf">Supplemental Terms and Conditions for iOpenAccess articles published in Informa Healthcare journals</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Acrylonitrile is an IARC class 2B carcinogen present in cigarette smoke. Urinary 2-cyanoethylmercapturic acid (CEMA) is an acrylonitrile metabolite and a potential biomarker for acrylonitrile exposure. The objective of this work was to study the dose response of CEMA in urine of non-smokers and smokers of different ISO tar yield cigarettes. We observed that smokers excreted &#x0003e;100-fold higher amounts of urinary CEMA than non-smokers. The CEMA levels in smokers were significantly correlated with ISO tar yield, daily cigarette consumption, and urinary biomarkers of smoke exposure. In conclusion, urinary CEMA is a suitable biomarker for assessing smoking-related exposure to acrylonitrile.</p></abstract><kwd-group><kwd>Acrylonitrile</kwd><kwd>2-cyanoethylmercapturic acid (CEMA)</kwd><kwd>cigarette smoking</kwd><kwd>exposure</kwd></kwd-group></article-meta></front><body><sec sec-type=""><title>Introduction</title><p>Acrylonitrile is used in the production of acrylic and modacrylic fibers, copolymers, adipinonitrile, acrylamide and other industrial chemicals (<xref ref-type="bibr" rid="b9">IARC, 1979</xref>; <xref ref-type="bibr" rid="b10">IARC, 1999</xref>). General population exposure to acrylonitrile is limited to tobacco smoke, accidental fires, and residual acrylonitrile in commercial polymeric material (<xref ref-type="bibr" rid="b18">Leonard <italic>et al</italic>., 1999</xref>). Tobacco smoke is by far the major non-occupational source for acrylonitrile exposure.</p><p>Ranges for mainstream smoke yields were reported to amount to 4.4 - 11.9 and 7.8 - 39.1 &#x003bc;g/cigarette when machine smoked with ISO and Massachusetts smoking parameters, respectively (<xref ref-type="bibr" rid="b11">IARC, 2004</xref>). The corresponding sidestream smoke yields amount to 24.1-85.6 &#x003bc;g/ cigarette (<xref ref-type="bibr" rid="b11">IARC, 2004</xref>). The ambient air concentration of acrylonitrile due to environmental tobacco smoke (ETS) was estimated to be 0.1-1.9 &#x003bc;g/m<sup>3</sup> (<xref ref-type="bibr" rid="b20">Miller <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="b16">Jenkins <italic>et al</italic>., 2000</xref>).</p><p>The International Agency for Research on Cancer (IARC) has classified acrylonitrile as a &#x02018;possible human carcinogen&#x02019; (2B) (<xref ref-type="bibr" rid="b10">IARC, 1999</xref>). The evidence for this classification is mainly based on rat inhalation studies which reported nervous system, mammary, and hepatic tumors (<xref ref-type="bibr" rid="b10">IARC, 1999</xref>). Acrylonitrile was also shown to be mutagenic in some <italic>in vitro</italic> test systems, including the Ames assay (<xref ref-type="bibr" rid="b18">Leonard <italic>et al</italic>., 1999</xref>). At high doses, acrylonitrile is toxic to the central nervous system, gastrointestinal tract, and adrenals (<xref ref-type="bibr" rid="b18">Leonard <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="b29">Thier <italic>et al</italic>., 2000</xref>).</p><p>Once absorbed in the body, acrylonitrile is metabolized through: (i) Epoxidation to glycidonitrile, which in turn can form DNA and protein adducts and several other metabolites including cyanide (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="b17">Lambotte-Vandepaer <italic>et al</italic>., 1985</xref>; <xref ref-type="bibr" rid="b8">Fennell <italic>et al</italic>., 2000</xref>). (ii) Nucleophilic reaction with glutathione (GSH) and proteins (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="b17">Lambotte-Vandepaer <italic>et al</italic>., 1985</xref>; <xref ref-type="bibr" rid="b7">Fennell <italic>et al</italic>., 1991</xref>; <xref ref-type="bibr" rid="b28">Sumner <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="b29">Thier <italic>et al</italic>., 2000</xref>).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Simplified metabolic pathway of acrylonitrile, modified from Leonard <italic>et al</italic>., 1999. GSH:glutathione, GST: glutathione S-transferase, Hb: haemoglobin.</p></caption><graphic xlink:href="tbmk16-089-f1"/></fig><p>As final products of the reaction with GSH, a number of mercapturic acids are formed which are excreted into the urine, the most important of which is 2-cyanoethylmercapturic acid (CEMA) (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="b7">Fennell <italic>et al</italic>., 1991</xref>; <xref ref-type="bibr" rid="b28">Sumner <italic>et al</italic>., 1997</xref>).</p><p>In order to test a biomarker's suitability, an assessment of specificity, sensitivity, reproducibility, and the qualification of a dose-response relationship is required. Recently, Schettgen <italic>etal.</italic> reported 120-fold higher urinary CEMA levels in smokers compared to non-smokers (<xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>., 2009</xref>). Furthermore, a gradual increase in CEMA excretion was correlated to urinary cotinine (<xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>., 2009</xref>). In 2010, Scherer and colleagues described a method to quantify acrylonitrile and other alkylating agents (<xref ref-type="bibr" rid="b22">Scherer <italic>et al</italic>., 2010</xref>). It was applied to a group of smokers of conventional cigarette products, a group of highly activated carbon filter cigarette smokers, and a group of quitters. Although a difference could be observed between the groups this work did not address the dose response relationship of CEMA as biomarker and the correlation with other cigarette smoke biomarkers.</p><p>Here, we investigated the dose-response relationship between smoking-related acrylonitrile exposure and CEMA excretion. The level of urinary CEMA in smokers of different ISO taryield cigarettes (1, 4, and 10mg)were compared with a variety of nicotine exposure biomarkers including Tneq (total nicotine equivalent) and nicotine MLE (mouth level exposure). Correlations were also established with two biomarkers of exposure to smoke toxicants, namely 3-HPMA (3-hydroxypropyl mercapturic acid), and NNAL, which are metabolites of acrolein and NNK(4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone), respectively. The results presented in this report show that urinary CEMA is a robust biomarker of exposure.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title/><sec><title>Chemicals and standards</title><p>N-Acetyl-S-(2-cyanoethyl)-L-cysteine (2-cyanoetehylmercapturic acid, CEMA), and [d<sub>3</sub>]-N-acetyl-S-(2-cyanoethyl)-L-cysteine (CEMA-d<sub>3</sub>) were purchased from Toronto Research Chemicals, North York, Ontario, Canada. The supplier stated a chemical purity of 98 % or greater for all reference compounds. Results of this study were not corrected for purity.</p><p>Ammonium formate (&#x0003e; 99 %) was obtained from Sigma-Aldrich, Taufkirchen, Germany. Formic acid (98 - 100 %) and acetonitrile (for HPLC) were purchased from Merck, Darmstadt, Germany. Deionized water was prepared with Seradest equipment (Munich, Germany). All chemicals were of analytical grade or higher.</p></sec><sec><title>Analytical methods - Smoke chemistry</title><p>Three US king size commercial brands of 1, 4.7, and 10.5 mg/ cig ISO tar yields were used in this study. These products are referred as 1, 4, and 10 mg cigarettes, respectively. Smoke chemistry for the 1,4, and 10 mg ISO Tar products was analysed by GC-MS following a method adapted from Dong and colleagues (<xref ref-type="bibr" rid="b5">Dong <italic>et al</italic>., 2000</xref>). Briefly, conditioned cigarettes were smoked (three replicates) using a Borgwaldt RM20/CS smoking machine set to ISO (35 ml puff volume, 2 sec puff duration every 60 sec) and Massachusetts (45 ml puff, 2 sec puff duration every 30 sec, 50% vent holes blocked) standard smoking regimes (<xref ref-type="bibr" rid="b13">International Organization for Standardization, 2000</xref>; <xref ref-type="bibr" rid="b19">Massachusetts General Law, 1997</xref>). The generated smoke passed through a 44mm Cambridge Filter Pad (CFP), to remove particulates, before the remaining vapour phase was collected in a 3L Tedlar bag. Internal standard, deuterated acrylonitrile, was added before a precise volume (0.5mL) was injected into a GC/MS system (Agilent 6890) fitted with a RTX-VMS column (length 30 m, 0.32 mm i.d., 1.8um film thickness) for separation and analysis. Acrylonitrile was detected and quantified using a target ion at 52 m/z and two qualifier ions at 53 and 38 m/z.</p></sec><sec><title>Analytical methods - Urinary biomarkers</title><p>The determination of CEMA in urine was performed using a method adapted from Schettgen et al. (<xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>., 2009</xref>), and validated according to the U.S. Food and Drug Administration guidelines for bioanalytical methods (<xref ref-type="bibr" rid="b6">FDA, 2001</xref>). In brief, 0.5 ml 50 mM ammonium formate buffer, pH 2.5 and 10 &#x003bc;l internal standard (IS) solution (100ng CEMA-d<sub>3</sub> in 0.1 % formic acid) were added to 0.5 ml of urine vortexed and centrifuged (3000 &#x000d7;g, 10min). Fifty (50) &#x003bc;l of this mixture was injected into an LC-MS/MS system, consisting of a Model 1200 HPLC device (Agilent Technologies, Waldbronn, Germany) and an atmospheric pressure ionization triple quadrupole mass spectrometer (Sciex API 5000, Applied Biosystems, Darmstadt, Germany). RAM (Restricted Access Material), chromatographic column, and mobile phases were as described in <xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>., 2009</xref>. Gradient and valve positions are summarized in <xref ref-type="table" rid="tbl1">Table 1</xref>.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Column switching and gradient program of the LC-MS/MS for CEMA in urine. Mobile phase: A: water, 0.1% formic acid; B: 40% A and 60% acetonitrile v/v.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Time (min)</th><th align="center" rowspan="1" colspan="1">Mobile phase A (%)</th><th align="center" rowspan="1" colspan="1">Valve position</th><th align="left" rowspan="1" colspan="1">Chromatographic step</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">RAM sample loading</td></tr><tr><td align="left" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">B</td><td align="left" rowspan="1" colspan="1">Backflushing - RAM sample clean up</td></tr><tr><td align="left" rowspan="1" colspan="1">1.3</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">Injection</td></tr><tr><td align="left" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">Separation</td></tr><tr><td align="left" rowspan="1" colspan="1">8.0</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">10.0</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">17.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">Washing</td></tr><tr><td align="left" rowspan="1" colspan="1">21.0</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">25.0</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">Reconditioning</td></tr></tbody></table></table-wrap><p>Negative electrospray ionization (ESI-) was applied, and the MS/MS system was run in the multi-reaction monitoring (MRM) mode. Retention times as well as the quantifier and qualifier mass transitions of the analyte (CEMA) and the IS (CEMA-d<sub>3</sub>) are shown in <xref ref-type="table" rid="tbl2">Table 2</xref>. The mean quantifier/qualifier ratio was 0.7, acceptance criteria were +/-25%, which were met by all samples analyzed. LOD was estimated by extrapolating the signal to noise ratio S/N = 3 from a non-smoker urine sample with low CEMA background.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Retention times (RT) and mass transitions for CEMA and the internal standard (CEMA-d<sub>3</sub>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">RT(min)</th><th align="center" rowspan="1" colspan="1">Parent ion (m/z)</th><th align="center" rowspan="1" colspan="1">Daughter ion (m/z)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CEMA quantifier</td><td align="center" rowspan="1" colspan="1">13.85</td><td align="center" rowspan="1" colspan="1">215</td><td align="center" rowspan="1" colspan="1">162</td></tr><tr><td align="left" rowspan="1" colspan="1">CEMA qualifier</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">215</td><td align="center" rowspan="1" colspan="1">86</td></tr><tr><td align="left" rowspan="1" colspan="1">CEMA-d<sub>3</sub> quantifier</td><td align="center" rowspan="1" colspan="1">13.8</td><td align="center" rowspan="1" colspan="1">218</td><td align="center" rowspan="1" colspan="1">165</td></tr><tr><td align="left" rowspan="1" colspan="1">CEMA-d<sub>3</sub> qualifier</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">218</td><td align="center" rowspan="1" colspan="1">86</td></tr></tbody></table></table-wrap><p>The method was calibrated by spiking non-smokers pooled urine with CEMA at concentrations of 2.0 to 1000ng/ml. The analyte/IS ratio of the unspiked urine (zero calibrator) was subtracted from each calibrator. Linear regression was applied for the calculation of the calibration function and the regression line was forced through the origin.</p><p>Mouth level exposure (MLE) to nicotine was estimated using previously described methodology (<xref ref-type="bibr" rid="b25">Shepperd <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="b27">St Charles <italic>et al</italic>., 2006</xref>). Briefly, filter tips are collected and nicotine is extracted with methanol for quantification by gas chromatography which provides an estimate of human-smoked cigarette yields. Urinary total nicotine equivalents (Tneq) is calculated as the sum of urinary nicotine, cotinine, and trans-S'-hydroxycotinine following (3-glucuronidase treatment (<xref ref-type="bibr" rid="b31">Xu <italic>et al</italic>., 2004</xref>), 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL), and 3-hydroxypropylm-ercapturic acid (3-HPMA) were also determined, using previously described methodologies (<xref ref-type="bibr" rid="b21">Scherer <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="b26">Shepperd <italic>et al</italic>., 2009</xref>).</p></sec><sec><title>Urine Samples</title><p>One hundred and ninety (190) 24h-urine samples stored at -25 &#x000b0;C were taken from a previous clinical study performed in Germany (<xref ref-type="bibr" rid="b26">Shepperd <italic>et al</italic>., 2009</xref>). Twenty four (24) hours urine samples were obtained from healthy smoking (n=140) and nonsmoking (n = 50) volunteers. The smokers belonged to three groups, smoking cigarettes with 10 mg (n = 47), 4mg (n = 45), or 1mg (n = 48) tar as nicotine-free dry particulate matter (NFDPM), determined according to the ISO standard smoking regime. Demographic analysis showed a normal distribution for the BMI (body mass index) with no differences between groups; however, more females (63%) were recruited in the 1 mg product category and more males were recruited in the non-smoker group (62%) and the 10 mg group (68%). The urine samples were initially collected in the course of 2006 during a residential visit to the clinic. Each group stayed at the clinic at different days to ensure compliance and limit environmental exposure for the non-smoker group. Biomarker analyses were performed in 2007 for MLE, Tneq, 3-HPMA, and NNAL and the data was reported in <xref ref-type="bibr" rid="b26">Shepperd <italic>et al</italic>., 2009</xref>. CEMA data was acquired in 2009 following analysis of the stored samples. Freeze thaw cycles and long-term storage stability for CEMA for two months (<xref ref-type="bibr" rid="b22">Scherer <italic>et al</italic>., 2010</xref>) and up to one year (data not shown) did not indicate any instability.</p><p>The study protocol and informed consent forms were approved by the Ethics Committee of the &#x000c4;rztekammer Hamburg, Germany and the clinical study was conducted in accordance with the World Medical Association Declaration of Helsinki (<xref ref-type="bibr" rid="b30">World Medical Association, 2004</xref>) and International Conference on Harmonisation (ICH) Guidelines for Good Clinical Practice (GCP) (<xref ref-type="bibr" rid="b12">International Conference on Harmonization, 1996</xref>).</p></sec><sec><title>Statistics</title><p>All statistical analyses were carried out with MINITAB v15.1 (MINITAB Inc., Quality Plaza, 1829 Pine Hall Rd, State College, PA 16801-3008, USA). Summary statistics were computed for urinary CEMA, and other markers of smoke exposure (MLE to nicotine, Tneq, NNAL, 3-HPMA, and cigarettes per day) taken from the study by <xref ref-type="bibr" rid="b26">Shepperd <italic>et al</italic>., 2009</xref>. A correlation matrix was produced to test relationships across the different CEMA and markers of exposure. Analysis of variance was carried out with ISO tar yield as a factor followed by post ANOVA comparisons (Tukey's HSD test). Tukey's HSD test determines which means amongst a set of means differs from the rest (<xref ref-type="bibr" rid="b1">Altman., 1991</xref>).</p></sec></sec></sec><sec sec-type=""><title>Results</title><sec><title>Smoke chemistry</title><p>To demonstrate that the selected products (1, 4, and 10mg ISO tar) yielded different amounts of acrylonitrile, mainstream smoke acrylonitrile levels were quantified under the ISO and Massachusetts smoking regime. The results are reported in <xref ref-type="table" rid="tbl3">Table 3</xref> and showed an increase in acrylonitrile levels between the lower and the higher tar band products and according to smoking regime intensity.</p><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p>Mainstream acrylonitrile content in smoke of 1, 4, and 10 mg ISO tar products used in this study. Data is reported for the standard ISO and Massachusetts smoking regimes.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">ISO Tar yields (mg/cig)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.7</td><td align="center" rowspan="1" colspan="1">10.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Acrylonitrile ISO regime (&#x003bc;g/cig)</td><td align="center" rowspan="1" colspan="1">0.72&#x000b1;0.07</td><td align="center" rowspan="1" colspan="1">2.89&#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">7.56&#x000b1;0.37</td></tr><tr><td align="left" rowspan="1" colspan="1">Massachusetts Tar yields (mg/cig)</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">13.6</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="left" rowspan="1" colspan="1">Acrylonitrile Massachusetts regime (ng/cig)</td><td align="center" rowspan="1" colspan="1">9.21&#x000b1;0.46</td><td align="center" rowspan="1" colspan="1">12.36&#x000b1;0.46</td><td align="center" rowspan="1" colspan="1">18.18&#x000b1;0.4</td></tr></tbody></table></table-wrap></sec><sec><title>Performance of the LC-MS/MS method for CEMA in urine</title><p>Performance data for the CEMA analytical method are summarized in <xref ref-type="table" rid="tbl4">Table 4</xref>. Ranges for intra- and inter-day precisions were 0.9 - 2.6 and 2.9 - 5.6 %, respectively. Accuracy of method was 92.4 % at high (300 ng/ ml) and 102.5 % at low (3.0ng/ml) levels. LOD and LOQ were at 0.06 and 0.17 ng/ml, respectively, allowing quantification of CEMA in all urine samples, including that of non-smokers.</p><table-wrap id="tbl4" position="float"><label>Table 4</label><caption><p>Method performance for the determination of CEMA in urine.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">Precision</td><td align="left" rowspan="1" colspan="1">Intra-day(n = 10)</td><td align="left" rowspan="1" colspan="1">5.1ng/ml</td><td align="left" rowspan="1" colspan="1">2.60%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">150ng/m</td><td align="left" rowspan="1" colspan="1">2.00%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">278ng/ml</td><td align="left" rowspan="1" colspan="1">0.90%</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Inter-day (5 days)</td><td align="left" rowspan="1" colspan="1">5.1ng/ml</td><td align="left" rowspan="1" colspan="1">2.90%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">150ng/ml</td><td align="left" rowspan="1" colspan="1">5.60%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">278ng/ml</td><td align="left" rowspan="1" colspan="1">4.30%</td></tr><tr><td align="left" rowspan="1" colspan="1">Accuracy</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.0ng/ml(n = 4)</td><td align="left" rowspan="1" colspan="1">102.50%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">150ng/ml(n = 5)</td><td align="left" rowspan="1" colspan="1">98.60%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">300ng/ml(n = 3)</td><td align="left" rowspan="1" colspan="1">92.40%</td></tr><tr><td align="left" rowspan="1" colspan="1">LOD</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.06ng/ml</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">LOQ</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.17ng/ml</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Linearity</td><td align="left" rowspan="1" colspan="1">(LOQ-ULOQ)</td><td align="left" rowspan="1" colspan="1">2.0-1000ng/ml</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R2 = 0.99975</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec><title>Urinary CEMA excretion in non-smokers and smokers</title><p>Urinary CEMA in non-smokers and smokers of 1, 4, and 10 mg ISO tar band products was quantified using the LC-MS/MS method described above. CEMA levels in urine of non-smokers were significantly lower than in urine of smokers (<xref ref-type="fig" rid="fig2">Figure 2</xref>) and mean CEMA levels increased with the ISO tar levels (<xref ref-type="fig" rid="fig2">Figure 2</xref>) (<xref ref-type="table" rid="tbl5">Table 5</xref>). CEMA excretion was significantly higher in smokers of 10mg ISO tar cigarettes compared to smokers of 1mg and 4mg ISO tar cigarettes (p&#x0003c;0.001) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The difference was still significant between smokers of 1 mg and 4mg cigarettes (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The number of cigarettes smoked daily was not significantly different between the 1 and4mggroup andthe4and 10mggroup (p&#x0003e;0.05),but was significantly different between the 1 and 10 mg group (<xref ref-type="table" rid="tbl5">Table 5</xref>). The number of cigarettes/day, however, is not the most reliable indicator of tobacco smoke exposure. Therefore the correlation between CEMA and multiple cigarette smoke exposure markers such as Tneq and nicotine MLE was also evaluated to determine a dose-response relationship.</p><table-wrap id="tbl5" position="float"><label>Table 5</label><caption><p>Summary statistics for CEMA and selected markers of tobacco smoke exposure in the urine of smokers and non-smokers (NS).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">StDev</th><th align="center" rowspan="1" colspan="1">Median</th><th align="center" rowspan="1" colspan="1">Tukey group</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">cig/day</td><td align="left" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1mg</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">16.8</td><td align="center" rowspan="1" colspan="1">6.6</td><td align="center" rowspan="1" colspan="1">15.0</td><td align="center" rowspan="1" colspan="1">a</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4mg</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">19.2</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">18.0</td><td align="center" rowspan="1" colspan="1">ab</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10mg</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">20.1</td><td align="center" rowspan="1" colspan="1">5.1</td><td align="center" rowspan="1" colspan="1">20.0</td><td align="center" rowspan="1" colspan="1">b</td></tr><tr><td align="left" rowspan="1" colspan="1">3-HPMA (&#x003bc;g/24h)</td><td align="left" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">228.4</td><td align="center" rowspan="1" colspan="1">70.4</td><td align="center" rowspan="1" colspan="1">231.6</td><td align="center" rowspan="1" colspan="1">a</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1mg</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">810.7</td><td align="center" rowspan="1" colspan="1">559.7</td><td align="center" rowspan="1" colspan="1">680.4</td><td align="center" rowspan="1" colspan="1">b</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4mg</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">1231.0</td><td align="center" rowspan="1" colspan="1">687.0</td><td align="center" rowspan="1" colspan="1">1129.0</td><td align="center" rowspan="1" colspan="1">c</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10mg</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">1945.0</td><td align="center" rowspan="1" colspan="1">968.0</td><td align="center" rowspan="1" colspan="1">1806.0</td><td align="center" rowspan="1" colspan="1">d</td></tr><tr><td align="left" rowspan="1" colspan="1">Total NNAL (ng/24h)</td><td align="left" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">12.7</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">11.1</td><td align="center" rowspan="1" colspan="1">a</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1mg</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">173.0</td><td align="center" rowspan="1" colspan="1">125.5</td><td align="center" rowspan="1" colspan="1">136.7</td><td align="center" rowspan="1" colspan="1">b</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4mg</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">274.1</td><td align="center" rowspan="1" colspan="1">144.2</td><td align="center" rowspan="1" colspan="1">276.0</td><td align="center" rowspan="1" colspan="1">c</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10mg</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">486.0</td><td align="center" rowspan="1" colspan="1">235.5</td><td align="center" rowspan="1" colspan="1">426.6</td><td align="center" rowspan="1" colspan="1">d</td></tr><tr><td align="left" rowspan="1" colspan="1">nicotine MLE (mg/day)</td><td align="left" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">-<xref ref-type="table-fn" rid="tf5-1">a</xref></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1mg</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">14.0</td><td align="center" rowspan="1" colspan="1">8.7</td><td align="center" rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">a</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4mg</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">18.4</td><td align="center" rowspan="1" colspan="1">7.6</td><td align="center" rowspan="1" colspan="1">19.9</td><td align="center" rowspan="1" colspan="1">ab</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10mg</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">29.9</td><td align="center" rowspan="1" colspan="1">11.9</td><td align="center" rowspan="1" colspan="1">28.5</td><td align="center" rowspan="1" colspan="1">c</td></tr><tr><td align="left" rowspan="1" colspan="1">Tneq (mg/24h)</td><td align="left" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">a</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1mg</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">7.1</td><td align="center" rowspan="1" colspan="1">4.8</td><td align="center" rowspan="1" colspan="1">5.6</td><td align="center" rowspan="1" colspan="1">b</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4mg</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1">6.2</td><td align="center" rowspan="1" colspan="1">12.1</td><td align="center" rowspan="1" colspan="1">c</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10mg</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">18.8</td><td align="center" rowspan="1" colspan="1">8.2</td><td align="center" rowspan="1" colspan="1">17.1</td><td align="center" rowspan="1" colspan="1">d</td></tr><tr><td align="left" rowspan="1" colspan="1">CEMA (&#x003bc;g/24h)</td><td align="left" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">1.3</td><td align="center" rowspan="1" colspan="1">0.7</td><td align="center" rowspan="1" colspan="1">1.1</td><td align="center" rowspan="1" colspan="1">a</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1mg</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">96.9</td><td align="center" rowspan="1" colspan="1">81.8</td><td align="center" rowspan="1" colspan="1">75.4</td><td align="center" rowspan="1" colspan="1">b</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4mg</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">139.3</td><td align="center" rowspan="1" colspan="1">72.1</td><td align="center" rowspan="1" colspan="1">140.2</td><td align="center" rowspan="1" colspan="1">c</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10mg</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">214.8</td><td align="center" rowspan="1" colspan="1">113.8</td><td align="center" rowspan="1" colspan="1">186.6</td><td align="center" rowspan="1" colspan="1">d</td></tr></tbody></table><table-wrap-foot><fn id="tf5-1"><label>a</label><p>MLE not relevant for non-smokers</p></fn></table-wrap-foot></table-wrap><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Boxplots of urinary CEMA excretion rates by smoking status and ISO tar yields of the smoked cigarettes. Circles represent means, centre lines in the boxes represent medians. The upper whisker extends to the highest data value within the upper limit (Upper limit = Q3 +1.5 (Q3 - Q1), while the lower whisker extends to the lowest value within the lower limit (Lower limit = Q1 -1.5 (Q3 - Q1)) where Q1 and Q3 are the 25th and 75th percentiles, respectively. Asterisks represent the outliers</p></caption><graphic xlink:href="tbmk16-089-f2"/></fig></sec><sec><title>Correlation of urinary CEMA with other biomarkers of smoke exposure</title><p>Urinary CEMA levels were correlated with both, biomarkers of tobacco consumption (urinary Tneq, and nicotine MLE) and biomarkers of smoke toxicants exposure (urinary NNAL and 3-HPMA). Significant correlations (p&#x0003c;0.001) were found between urinary CEMA and all the biomarkers analysed. The corresponding Pearson correlation coefficients (r) are presented in <xref ref-type="table" rid="tbl6">Table 6</xref> and the matrix plots for the regression are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><table-wrap id="tbl6" position="float"><label>Table 6</label><caption><p>Pearson correlation matrix between CEMA and markers of smoking dose.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">cigs/day</th><th align="center" rowspan="1" colspan="1">3-HPMA (&#x003bc;g/24h)</th><th align="center" rowspan="1" colspan="1">Total NNAL (ng/24h)</th><th align="center" rowspan="1" colspan="1">Nicotine MLE (mg/day)</th><th align="center" rowspan="1" colspan="1">Tneq (mg/24h)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">3-HPMA (&#x003bc;g/24h)</td><td align="center" rowspan="1" colspan="1">0.71 p &#x0003c; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Total NNAL (ng/24h)</td><td align="center" rowspan="1" colspan="1">0.705 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.865 p &#x0003c; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nicotine MLE (mg/day)</td><td align="center" rowspan="1" colspan="1">0.727 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.806 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.714 p &#x0003c; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Tneq (mg/24h)</td><td align="center" rowspan="1" colspan="1">0.758 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.913 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.932 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.761 p &#x0003c; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CEMA (&#x003bc;g/24h)</td><td align="center" rowspan="1" colspan="1">0.738 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.885 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.840 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.762 p &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1">0.869 p &#x0003c; 0.001</td></tr></tbody></table></table-wrap><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Scatterplots of CEMA versus biomarkers showing regression lines bordered by 95% prediction intervals. Key to scatterplot groups: <inline-formula><inline-graphic xlink:href="tbmk16-089-f4.jpg"/></inline-formula> NS, <inline-formula><inline-graphic xlink:href="tbmk16-089-f5.jpg"/></inline-formula>1mg, <inline-formula><inline-graphic xlink:href="tbmk16-089-f6.jpg"/></inline-formula>4mg, <inline-formula><inline-graphic xlink:href="tbmk16-089-f7.jpg"/></inline-formula> 10mg. A. CEMA <italic>vs</italic> Tneq, B. CEMA <italic>vs</italic> MLE nicotine, C. CEMA <italic>vs</italic> 3-HPMA, D. CEMA <italic>vs</italic> NNAL.</p></caption><graphic xlink:href="tbmk16-089-f3"/></fig></sec></sec><sec sec-type=""><title>Discussion</title><p>Biomarkers of exposure are widely regarded as the best indicators of the level of internal or absorbed dose of a toxicant in exposed subjects. Biomarkers of exposure are critical for evaluating the impact of new strategies or products that aim to reduce exposure to tobacco smoke toxicants. In this context, the development of accurate methods and careful characterization of biomarkers specificity, sensitivity, and ability to denote a dose-response relationship which is understood on a mechanistic basis is essential (<xref ref-type="bibr" rid="b14">IOM, 2001</xref>).</p><p>Acrylonitrile is an IARC class 2B carcinogen present in tobacco smoke which has been recommended for monitoring in tobacco products in the 2008 TobReg proposal (<xref ref-type="bibr" rid="b4">Burns <italic>et al</italic>., 2008</xref>). Jakuboswki and colleagues showed that volunteers who were experimentally exposed to 5 or 10mg/m<sup>3</sup> acrylonitrile excreted, on average, 21.8 % of the retained dose as CEMA in their urine (<xref ref-type="bibr" rid="b15">Jakubowski <italic>et al</italic>., 1987</xref>). However this study was performed with only six subjects and the correlation between absorbed dose of acrylonitrile and excretion of CEMA gave equivocal results. In a recent study, Schettgen and colleagues quantified CEMA in urine of smokers (n = 81), passive smokers (n = 38), and non-smokers (n = 73) and demonstrated a good correlation between urinary CEMA and cotinine levels (<xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>., 2009</xref>).</p><p>The aim of this work was to further evaluate CEMA as a dose-dependent biomarker of acrylonitrile exposure using 24h-urine samples of non-smokers and smokers of different ISO tar band cigarettes (1 mg, 4mg, and 10 mg). CEMA was quantified using a validated LC-MS/ MS method adapted from <xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>, 2009</xref>.</p><p>Performance data for the method complied with the validation criteria of the US FDA (<xref ref-type="bibr" rid="b6">FDA, 2001</xref>). In particular, the LOQ (0.17ng/ml) was low enough to allow quantification of CEMA in background exposed non-smokers (<xref ref-type="table" rid="tbl4">Table 4</xref>). Furthermore, the column switching technique, which consisted of an on-line purification and concentration of the analyte prior to chromatography on a C8 analytical column, allowed full automation of the method resulting in high throughput (50&#x02013;55 samples/day).</p><p>Following analysis of the urine samples, the results showed that smokers excreted between 75- and 165-fold higher amounts of the acrylonitrile biomarker CEMA than non-smokers (<xref ref-type="table" rid="tbl5">Table 5</xref>). <xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>., 2009</xref> reported urinary median CEMA levels of 2.0 &#x003bc;g/1 in non-smokers, 3.2-6.6 &#x003bc;g/1 in passive smokers, and 240 &#x003bc;g/1 in smokers. Absolute CEMA levels as well as smoker/non-smoker ratios (36 &#x02013; 120, depending on the extent of ETS exposure) were in good agreement with the results from this study. A rough estimate of the percentage of acrylonitrile excreted as CEMA can be calculated assuming that: (i) the average smoking pattern is similar to the Massachusetts smoking regime, (ii) 50% of the acrylonitrile is retained and absorbed through the lungs (<xref ref-type="bibr" rid="b15">Jakubowski <italic>et al</italic>., 1987</xref>), (iii) the average background exposure to acrylonitrile is reflected by the CEMA level observed in non-smokers (1.3 &#x003bc;g CEMA/24hrs urine) and is subtracted from CEMA levels in smokers. With these assumptions, the percentage of smoking-related acrylonitrile appearing as CEMA in urine amount to 30.3, 28.5 and 28.7% which is in close agreement with the figure provided by Jakubowski <italic>et al.</italic> (21.8%).</p><p>Studies on the smoking-related exposure to acrylonitrile have been performed in the past with the long-term biomarker of exposure CEVal (cyanoethylvaline) haemoglobin adducts. Smokers were found to have 17- to 61-fold higher CEVal levels than non-smokers (<xref ref-type="bibr" rid="b7">Fennell <italic>et al</italic>., 1991</xref>; <xref ref-type="bibr" rid="b2">Bergmark, 1997</xref>; <xref ref-type="bibr" rid="b23">Schettgen <italic>et al</italic>., 2002</xref>, <xref ref-type="bibr" rid="b21">Scherer <italic>et al</italic>., 2007</xref>). This is in line with the urinary CEMA data and indicates that, with the exception of occupational exposures, acrylonitrile shows specificity for tobacco smoke exposure.</p><p>The CEMA results show a strong correlation of the acrylonitrile biomarker with various measures of smoking dose, such as daily cigarette consumption, MLE to nicotine, and urinary Tneq (r &#x0003e; 0.7, <xref ref-type="table" rid="tbl6">Table 6</xref>). This is in good agreement with the findings of <xref ref-type="bibr" rid="b24">Schettgen <italic>et al</italic>., 2009</xref> who reported a correlation coefficient of r = 0.734 between CEMA and cotinine in urine. Although cotinine is a recognized biomarker for tobacco exposure, its level is subject to variability due to metabolic enzyme polymorphisms and ethnicity (<xref ref-type="bibr" rid="b3">Bramer and Kallungal, 2003</xref>). Total nicotine equivalence Tneq is a more reliable measure of nicotine consumption as it is the sum of nicotine plus five of its metabolites therefore, covering a wider range of the total nicotine mass balance. In our study a slight improvement in the correlation coefficient was observed with a value of r = 0.869 for CEMA and Tneq and r = 0.822 for CEMA and cotinine.</p><p>A significant trend in urinary CEMA levels with increasing ISO tar levels and Tneq was also observed. This appears to reflect smoke chemistry measurements, which indicates a strong association between ISO tar and ISO or Massachusetts acrylonitrile yields of the cigarettes used in this study (<xref ref-type="table" rid="tbl3">Table 3</xref>).</p><p>CEMA was well correlated with other biomarkers of tobacco smoke toxicants exposure such as NNAL and 3-HPMA, two metabolic products of NNK and acrolein, respectively.</p><p>The confidence intervals in <xref ref-type="fig" rid="fig3">Figure 3</xref> represent the range of values inclusive of 95% of the data for all the categories confounded. For instance, in 24 hrs urine, a 20mg Tneq exposure would potentially correspond to a range of 100 to 300 &#x003bc;g CEMA. This illustrates the marked variability between data points, despite the strong correlation between biomarkers. A number of potential sources for the variation can be identified, including interindividual variation such as body mass index, diet, metabolism and polymorphisms, individual smoking and inhalation behavior, samples collection and storage, and instrument precision. This underlines the importance of an adequate study design to limit confounding factors.</p><p>In conclusion, the analytical method used for the determination of the urinary acrylonitrile biomarker CEMA is sufficiently sensitive and specific to detect differences between smokers and non-smokers. Urinary CEMA levels show a clear dose-response relationship to the smoking dose, such as daily cigarette consumption, MLE to nicotine and urinary Tneq. Finally, CEMA can also discriminate between smokers of different ISO tar yield cigarettes. The method is therefore appropriate to assess the quantitative changes in exposure associated with the use of tobacco products, including the switch to reduced exposure tobacco products.</p></sec></body><back><sec><title>Declaration of interest</title><p>This work was funded by British American Tobacco. ABF is a contract research organization which provides biomarkers analysis services to BAT.</p></sec><ref-list><title>Reference</title><ref id="b1"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>Practical statistics for medical research</article-title><year>1991</year><publisher-loc>London</publisher-loc><publisher-name>Chapman and Hall</publisher-name></element-citation></ref><ref id="b2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergmark</surname><given-names>E</given-names></name></person-group><article-title>Hemoglobin adducts of acrylamide and acrylo-nitrile in laboratory workers, smokers and nonsmokers</article-title><source>Chem. Res. <italic>Toxicol.</italic></source><year>1997</year><volume>10</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">9074806</pub-id></element-citation></ref><ref id="b3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bramer</surname><given-names>SL</given-names></name><name><surname>Kallungal</surname><given-names>BA</given-names></name></person-group><article-title>Clinical considerations in study designs that use cotinine as a biomarker</article-title><source>Biomarkers</source><year>2003</year><volume>8</volume><fpage>187</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">12944172</pub-id></element-citation></ref><ref id="b4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>DM</given-names></name><name><surname>Dybing</surname><given-names>E</given-names></name><name><surname>Gray</surname><given-names>N</given-names></name><name><surname>Hecht</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>C</given-names></name><name><surname>Sanner</surname><given-names>T</given-names></name><name><surname>O'Connor</surname><given-names>R</given-names></name><name><surname>Djordjevic</surname><given-names>M</given-names></name><name><surname>Dresler</surname><given-names>C</given-names></name><name><surname>Hainaut</surname><given-names>P</given-names></name><name><surname>Jarvis</surname><given-names>M</given-names></name><name><surname>Opperhuizen</surname><given-names>A</given-names></name><name><surname>Straif</surname><given-names>K</given-names></name></person-group><article-title>Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal</article-title><source>Tob. <italic>Control</italic></source><year>2008</year><volume>17</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">18375736</pub-id></element-citation></ref><ref id="b5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>JZ</given-names></name><name><surname>Glass</surname><given-names>JN</given-names></name><name><surname>Moldoveanu</surname><given-names>SC</given-names></name></person-group><article-title>A Simple GC-MS Technique for the Analysis of Vapour Phase Mainstream Cigarette Smoke</article-title><source>J. Microcolumn Separations</source><year>2000</year><volume>12</volume><fpage>142</fpage><lpage>152</lpage></element-citation></ref><ref id="b6"><element-citation publication-type="journal"><collab>FDA. Food and Drug Administration (FDA)</collab><article-title>Guidance for Industry - Bioanalytical Method Validation</article-title><year>2001</year><fpage>1</fpage><lpage>22</lpage></element-citation></ref><ref id="b7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fennell</surname><given-names>TR</given-names></name><name><surname>Kedderis</surname><given-names>GL</given-names></name><name><surname>Sumner</surname><given-names>SC</given-names></name></person-group><article-title>Urinary metabolites of [1,2,3-13C]acrylonitrile in rats and mice detected by 13C nuclear magnetic resonance spectroscopy</article-title><source>Chem. Res. <italic>Toxicol.</italic></source><year>1991</year><volume>4</volume><fpage>678</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">1807451</pub-id></element-citation></ref><ref id="b8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fennell</surname><given-names>TR</given-names></name><name><surname>MacNeela</surname><given-names>JP</given-names></name><name><surname>Morris</surname><given-names>RW</given-names></name><name><surname>Watson</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>CL</given-names></name><name><surname>Bell</surname><given-names>DA</given-names></name></person-group><article-title>Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes</article-title><source>Cancer Epidemiol. <italic>Biomarkers Prev.</italic></source><year>2000</year><volume>9</volume><fpage>705</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">10919741</pub-id></element-citation></ref><ref id="b9"><element-citation publication-type="journal"><collab>IARC., International Agency for Research on Cancer</collab><article-title>Acrylonitrile, acrylic and modacrylic fibres, and acrylonitrile-butadiene-styrene and styrene-acrylonitrile copolymers. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans</article-title><source>IARC Monographs on the Evaluation of Carcinogenic Risks to Humans</source><year>1979</year><volume>19</volume><fpage>73</fpage><lpage>113</lpage></element-citation></ref><ref id="b10"><element-citation publication-type="journal"><collab>IARC., Iternational Agency for Research on Cancer</collab><article-title>Acrylonitrile</article-title><source>IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 71</source><year>1999</year><fpage>43</fpage><lpage>108</lpage></element-citation></ref><ref id="b11"><element-citation publication-type="journal"><collab>IARC., International Agency for Research on Cancer</collab><article-title>Tobacco smoke and involuntary smoking</article-title><source>IARC Monographs on the Evaluation of Carcinogenic Risks to Humans</source><year>2004</year><volume>83</volume><fpage>1</fpage><lpage>1438</lpage><pub-id pub-id-type="pmid">15285078</pub-id></element-citation></ref><ref id="b12"><element-citation publication-type="journal"><collab>International Conference on Harmonization</collab><article-title>Harmonized tripartite guidelines for good clinical practice. Directive 91/507/EEC. The rules governing medicinal products in the European Community</article-title><year>1996</year></element-citation></ref><ref id="b13"><element-citation publication-type="journal"><collab>International Organization for Standardization</collab><article-title><italic>ISO Standard</italic> 3308, in Routine Analytical Cigarette-smoking Machine-definitions and standard conditions</article-title><year>2000</year><fpage>4</fpage></element-citation></ref><ref id="b14"><element-citation publication-type="journal"><collab>IOM</collab><article-title>Institute of Medicine. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction</article-title><year>2001</year></element-citation></ref><ref id="b15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubowski</surname><given-names>M</given-names></name><name><surname>Linhart</surname><given-names>I</given-names></name><name><surname>Pielas</surname><given-names>G</given-names></name><name><surname>Kopecky</surname><given-names>J</given-names></name></person-group><article-title>2-Cyanoethyl-mercapturic acid (CEMA) in the urine as a possible indicator of exposure to acrylonitrile</article-title><source>Br. J. Ind. <italic>Med.</italic></source><year>1987</year><volume>44</volume><fpage>834</fpage><lpage>840</lpage><pub-id pub-id-type="pmid">3689720</pub-id></element-citation></ref><ref id="b16"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>RA</given-names></name><name><surname>Guerin</surname><given-names>MR</given-names></name><name><surname>Tomkins</surname><given-names>BA</given-names></name></person-group><article-title>The chemistry of environmental tobacco smoke: composition and measurement</article-title><year>2000</year><edition>2nd ed</edition><publisher-loc>Boca Raton</publisher-loc><publisher-name>Lewis Publishers</publisher-name></element-citation></ref><ref id="b17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambotte-Vandepaer</surname><given-names>M</given-names></name><name><surname>Duverger-van</surname><given-names>BM</given-names></name><name><surname>Rollmann</surname><given-names>B</given-names></name></person-group><article-title>Metabolism and mutagenicity of acrylonitrile: an in vivo study</article-title><source>Environ. <italic>Mutagen.</italic></source><year>1985</year><volume>7</volume><fpage>655</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">3899631</pub-id></element-citation></ref><ref id="b18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>A</given-names></name><name><surname>Gerber</surname><given-names>GB</given-names></name><name><surname>Stecca</surname><given-names>C</given-names></name><name><surname>Rueff</surname><given-names>J</given-names></name><name><surname>Borba</surname><given-names>H</given-names></name><name><surname>Farmer</surname><given-names>PB</given-names></name><name><surname>Sram</surname><given-names>RJ</given-names></name><name><surname>Czeizel</surname><given-names>AE</given-names></name><name><surname>Kalina</surname><given-names>I</given-names></name></person-group><article-title>Mutagenicity, carcinogenicity, and teratogenicity of acrylonitrile</article-title><source>Mutat. Res</source><year>1999</year><volume>436</volume><fpage>263</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">10354525</pub-id></element-citation></ref><ref id="b19"><element-citation publication-type="other"><comment>Massachusetts General Law (1997) Ch. 94Sect. 307B, 105 Code of Massachusetts Regulation 660.000.</comment></element-citation></ref><ref id="b20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>SL</given-names></name><name><surname>Branoff</surname><given-names>S</given-names></name><name><surname>Nazaroff</surname><given-names>WW</given-names></name></person-group><article-title>Exposure to toxic air contaminants in environmental tobacco smoke: an assessment for California based on personal monitoring data</article-title><source>J. Expo. Anal. Environ. <italic>Epidemiol.</italic></source><year>1998</year><volume>8</volume><fpage>287</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">9679213</pub-id></element-citation></ref><ref id="b21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherer</surname><given-names>G</given-names></name><name><surname>Engl</surname><given-names>J</given-names></name><name><surname>Urban</surname><given-names>M</given-names></name><name><surname>Gilch</surname><given-names>G</given-names></name><name><surname>Janket</surname><given-names>D</given-names></name><name><surname>Riedel</surname><given-names>K</given-names></name></person-group><article-title>Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany</article-title><source>Regul. Toxicol. <italic>Pharmacol.</italic></source><year>2007</year><volume>47</volume><fpage>171</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">17034917</pub-id></element-citation></ref><ref id="b22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherer</surname><given-names>G</given-names></name><name><surname>Urban</surname><given-names>M</given-names></name><name><surname>Hagedorna</surname><given-names>H-W</given-names></name><name><surname>Serafin</surname><given-names>R</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Kapurb</surname><given-names>S</given-names></name><name><surname>Muhammad</surname><given-names>R</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Sarkarb</surname><given-names>M</given-names></name><name><surname>Roethig</surname><given-names>H-J</given-names></name></person-group><article-title>Determination of methyl-, 2-hydroxyethyl- and 2-cyanoethylm-ercapturic acids as biomarkers of exposure to alkylating agents in cigarette smoke</article-title><source>J. Chromatography B.</source><year>2010</year><volume>878</volume><fpage>2520</fpage><lpage>2528</lpage></element-citation></ref><ref id="b23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schettgen</surname><given-names>T</given-names></name><name><surname>Broding</surname><given-names>HC</given-names></name><name><surname>Angerer</surname><given-names>J</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name></person-group><article-title>Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acr-ylamide-biomarkers in occupational and environmental medicine</article-title><source>Toxicol. <italic>Lett.</italic></source><year>2002</year><volume>134</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12191862</pub-id></element-citation></ref><ref id="b24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schettgen</surname><given-names>T</given-names></name><name><surname>Musiol</surname><given-names>A</given-names></name><name><surname>Alt</surname><given-names>A</given-names></name><name><surname>Ochsmann</surname><given-names>E</given-names></name><name><surname>Kraus</surname><given-names>T</given-names></name></person-group><article-title>A method for the quantification of biomarkers of exposure to acrylonitrile and 1,3-butadiene in human urine by column-switching liquid chromatography-tandem mass spectrometry</article-title><source>Anal. Bioanal. <italic>Chem.</italic></source><year>2009</year><volume>393</volume><fpage>969</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">19018522</pub-id></element-citation></ref><ref id="b25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepperd</surname><given-names>CJ</given-names></name><name><surname>St Charles</surname><given-names>FK</given-names></name><name><surname>Lien</surname><given-names>M</given-names></name><name><surname>Dixon</surname><given-names>M</given-names></name></person-group><article-title>Validation of Methods for Determining Consumer Smoked Cigarette Yields from Cigarette Filter Analysis</article-title><source>Beitrage zur Tabakforschung International</source><year>2006</year><volume>22</volume><fpage>176</fpage><lpage>184</lpage></element-citation></ref><ref id="b26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepperd</surname><given-names>CJ</given-names></name><name><surname>Eldridge</surname><given-names>AC</given-names></name><name><surname>Mariner</surname><given-names>DC</given-names></name><name><surname>McEwan</surname><given-names>M</given-names></name><name><surname>Errington</surname><given-names>G</given-names></name><name><surname>Dixon</surname><given-names>M</given-names></name></person-group><article-title>A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure</article-title><source>Regul. Toxicol. Pharmacol.</source><year>2009</year><volume>55</volume><fpage>97</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">19539004</pub-id></element-citation></ref><ref id="b27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Charles</surname><given-names>FK</given-names></name><name><surname>Krautter</surname><given-names>GR</given-names></name><name><surname>Dixon</surname><given-names>M</given-names></name><name><surname>Mariner</surname><given-names>DC</given-names></name></person-group><article-title>A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites</article-title><source>Psychopharmacology (Berl)</source><year>2006</year><volume>189</volume><fpage>345</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">17028908</pub-id></element-citation></ref><ref id="b28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumner</surname><given-names>SC</given-names></name><name><surname>Selvaraj</surname><given-names>L</given-names></name><name><surname>Nauhaus</surname><given-names>SK</given-names></name><name><surname>Fennell</surname><given-names>TR</given-names></name></person-group><article-title>Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days</article-title><source>Chem. Res. Toxicol.</source><year>1997</year><volume>10</volume><fpage>1152</fpage><lpage>1160</lpage><pub-id pub-id-type="pmid">9348438</pub-id></element-citation></ref><ref id="b29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thier</surname><given-names>R</given-names></name><name><surname>Lewalter</surname><given-names>J</given-names></name><name><surname>Bolt</surname><given-names>HM</given-names></name></person-group><article-title>Species differences in acrylonitrile metabolism and toxicity between experimental animals and humans based on observations in human accidental poisonings</article-title><source>Arch. Toxicol.</source><year>2000</year><volume>74</volume><fpage>184</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">10959790</pub-id></element-citation></ref><ref id="b30"><element-citation publication-type="other"><collab>World Medical Association</collab><comment>Declaration of Helsinki - Recommendations guiding physicians in biomedical research involving human subjects. Adopted 1964, amended 1975, 1983,1989,1996, 2000, 2002, and 2004.</comment></element-citation></ref><ref id="b31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Iba</surname><given-names>MM</given-names></name><name><surname>Weisel</surname><given-names>CP</given-names></name></person-group><article-title>Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography-tandem mass spectrometry</article-title><source>Clin. Chem.</source><year>2004</year><volume>50</volume><fpage>2323</fpage><lpage>2330</lpage><pub-id pub-id-type="pmid">15472033</pub-id></element-citation></ref></ref-list></back></article>